Richard B. Lai Fatt
Plus aucun poste en cours
Profil
Richard B.
Lai Fatt has been Vice President of Corporate Development for Nventa Biopharmaceuticals Corp.
since joining the company in June 2007.
Prior to Nventa Biopharmaceuticals, Dr. Lai Fatt was Vice President of Corporate Development for Kalypsys, Inc. Prior to joining Kalypsys, he was Vice President of Business Development and Strategic Marketing for Isis Pharmaceuticals.
Dr. Lai Fatt held various positions at DuPont Merck Pharmaceuticals, Schering-Plough International, Schering Canada and Lederle Pharmaceuticals.
He received a BS from the University of Miami, Florida and a PhD degree in Biology from McMaster University, Hamilton, Ontario, Canada.
Anciens postes connus de Richard B. Lai Fatt
| Sociétés | Poste | Fin |
|---|---|---|
Nventa Biopharmaceuticals Corp.
 Nventa Biopharmaceuticals Corp. Medical SpecialtiesHealth Technology Nventa Biopharmaceuticals Corp. discovered, developed and commercialized stress protein-based therapeutic vaccines. The company was headquartered in Victoria, Canada. | Corporate Officer/Principal | - |
Formation de Richard B. Lai Fatt
| University of Miami | Undergraduate Degree |
| McMaster University | Doctorate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Nventa Biopharmaceuticals Corp.
Nventa Biopharmaceuticals Corp. Medical SpecialtiesHealth Technology Nventa Biopharmaceuticals Corp. discovered, developed and commercialized stress protein-based therapeutic vaccines. The company was headquartered in Victoria, Canada. | Health Technology |
